Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
12:00 AM - Hepatology 2021
31
1
2
3
4
7
8
9
10
11
13
14
15
16
18
19
20
21
22
23
24
25
27
28
29
30
1
2
World Nanotechnology Congress 2021
2021-03-29    
All Day
Nano Technology Congress 2021 provides you with a unique opportunity to meet up with peers from both academic circle and industries level belonging to Recent [...]
Nanomedicine and Nanomaterials 2021
2021-03-29    
All Day
NanoMed 2021 conference provides the best platform of networking and connectivity with scientist, YRF (Young Research Forum) & delegates who are active in the field [...]
Smart Materials and Nanotechnology
2021-03-29 - 2021-03-30    
All Day
Smart Material 2021 clears a stage to globalize the examination by introducing an exchange amongst ventures and scholarly associations and information exchange from research to [...]
Hepatology 2021
2021-03-30 - 2021-03-31    
All Day
Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range [...]
Annual Congress on  Dental Medicine and Orthodontics
2021-04-05 - 2021-04-06    
All Day
Dentistry Medicine 2021 is a perfect opportunity intended for International well-being Dental and Oral experts too. The conference welcomes members from every driving university, clinical [...]
World Climate Congress & Expo 2021
2021-04-06 - 2021-04-07    
All Day
Climatology is the study of the atmosphere and weather patterns over time. This field of science focuses on recording and analyzing weather patterns throughout the [...]
European Food Chemistry and Drug Safety Congress
2021-04-12 - 2021-04-13    
All Day
We invite you to meet us at the Food Chemistry Congress 2021, where we will ensure that you’ll have a worthwhile experience with scholars of [...]
Proteomics, Genomics & Bioinformatics
2021-04-12 - 2021-04-13    
All Day
Proteomics 2021 is one of the front platforms for disseminating latest research results and techniques in Proteomics Research, Mass spectrometry, Bioinformatics, Computational Biology, Biochemistry and [...]
Plant Science & Physiology
2021-04-17 - 2021-04-18    
All Day
The PLANT PHYSIOLOGY 2021 theme has broad interests, which address many aspects of Plant Biology, Plant Science, Plant Physiology, Plant Biotechnology, and Plant Pathology. Research [...]
Pollution Control & Sustainable 2021
2021-04-26 - 2021-04-27    
All Day
Pollution Control 2021 conference is organizing with the theme of “Accelerating Innovations for Environmental Sustainability” Conference Series llc LTD organizes environmental conferences series 1000+ Global [...]
Events on 2021-03-30
Hepatology 2021
30 Mar 21
Events on 2021-04-06
Events on 2021-04-17
Events on 2021-04-26
Latest News

OptimizeRx Announces Q4 2014 Results

OptimizeRx Announces Q4 2014 Results

Good day everyone and welcome to the OptimizeRx Corporation 2014 Annual Earnings Conference Call.

Following the initial discussion, there will be time for question from the participants in the call. Just as a reminder today’s conference is being recorded. A transcript will be available for 90 days or those interested parties who want a copy, please contact Doug Baker, in our Rochester, Michigan Headquarters.

Now for opening remarks and introductions, I would now like to turn the conference over to Doug Baker, Chief Financial Officer for OptimizeRx.

Doug Baker – Chief Financial Officer

Thanks, Victoria. I would like to start off by welcoming everybody to the conference call. And as you know, I’m going to start off by reading the Safe Harbor statement.

This conference contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933 as amended and such Section 21E of the Securities Act of 1934 amended. These forward-looking statements should not be used to make an investment decision, the words estimate, possible and seeking and similar expressions identify forward-looking statements, which speak only as for the date the statement was made.

The company undertakes no obligation to publicly update or revise any forward-looking statements whether because of new company information, future events or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified.

Further events and actual results could differ materially from those set forth and contemplated by or underlying the forward-looking statements, the risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effective government regulation, competition and other material risk.

At this point, I am now going to turn the call over to Dave Harrell, our CEO for some opening remarks.

Dave Harrell – Chairman and Chief Executive Office

Thank you, Doug, and thanks everybody. So today I wanted to just talk about we’re going highlight today four key buckets, the first key bucket is how we’re expanding pharmaceutical brands and budgets and how we not only did in the 2014 but how we’re going to move forward very aggressively in 2015. The second bucket we’re going to talk about expanding physician utilization in our current EHR Network. The third bucket we’re going to speak to is how we’re going to have expanded our promotional network in other EHRs and platforms. And then our last bucket focuses on our fourth objective which is to expand infrastructure and resources to fully support and exploit each of our three opportunities that I just listed.

So with that I wanted to make some opening comments as it relates to pumping out our success in each of these key areas and then bringing it to each of the leaders in our departments, so that they can speak to how we’re further going to ramp it up. In regards to sustaining the pharmaceutical brands and budget as you may have realized that looking at our 10-K, we were successful expanding our sales overall by 39% over 2013. We also increased promotional transactions of approximately 26% over 2013 and Doug will speak a little bit more about our financial performance that did improve.

Source